Dillard's, Inc.
DDS · NYSE
11/1/2025 | 8/2/2025 | 5/3/2025 | 2/1/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | -0.46 | -0.38 | 0.12 |
| FCF Yield | 1.63% | 0.82% | 3.76% | 4.69% |
| EV / EBITDA | 41.07 | 49.50 | 20.49 | 23.43 |
| Quality | ||||
| ROIC | 4.42% | 2.54% | 6.04% | 8.06% |
| Gross Margin | 41.24% | 34.64% | 44.56% | 36.05% |
| Cash Conversion Ratio | 1.41 | 1.19 | 1.42 | 1.70 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.24% | -1.76% | -1.97% | -1.97% |
| Free Cash Flow Growth | 154.35% | -72.15% | -38.22% | 140.20% |
| Safety | ||||
| Net Debt / EBITDA | -2.82 | -3.31 | -1.32 | -0.52 |
| Interest Coverage | 0.00 | -40.57 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.51 | 0.82 | 0.58 | 1.12 |
| Cash Conversion Cycle | 54.50 | 44.16 | 46.61 | 41.60 |